Equities

Beta Drugs Ltd

Beta Drugs Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)2,050.00
  • Today's Change-20.00 / -0.97%
  • Shares traded2.40k
  • 1 Year change+68.32%
  • Beta1.1742
Data delayed at least 15 minutes, as of Nov 13 2024 05:54 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments286192173
Total Receivables, Net923714531
Total Inventory564362262
Prepaid expenses5.243.273.13
Other current assets, total0.005.810.07
Total current assets1,7791,277970
Property, plant & equipment, net592581507
Goodwill, net272727
Intangibles, net261915
Long term investments07.797.79
Note receivable - long term1026044
Other long term assets----0.00
Total assets2,5411,9841,579
LIABILITIES
Accounts payable593402320
Accrued expenses------
Notes payable/short-term debt509148
Current portion long-term debt/capital leases374340
Other current liabilities, total1679482
Total current liabilities847630490
Total long term debt6070118
Total debt147203206
Deferred income tax--00
Minority interest------
Other liabilities, total635547
Total liabilities970755655
SHAREHOLDERS EQUITY
Common stock969696
Additional paid-in capital239239239
Retained earnings (accumulated deficit)1,236893588
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--00
Total equity1,5711,229923
Total liabilities & shareholders' equity2,5411,9841,579
Total common shares outstanding9.619.619.61
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.